![](https://news.europawire.eu/wp-content/uploads/2013/11/merck.jpg)
FDA clearance validates Eeva System, which enables in-vitro fertilization (IVF) clinicians to offer the proprietary Eeva Test and further demonstrates commitment by Merck Serono and Auxogyn to bring innovative technologies to the IVF community Eeva Test first-of-a-kind prognostic, non-invasive test that provides IVF clinicians … Read the full press release